1. In vitro and in silico inhibitory effects of synthetic and natural eugenol derivatives against the NorA efflux pump in Staphylococcus aureus
- Author
-
José P. Siqueira-Júnior, Cristina Rodrigues dos Santos Barbosa, Jaime Ribeiro Filho, Cícera Datiane de Morais Oliveira-Tintino, Erlânio Oliveira de Sousa, Gabriela Ribeiro de Sousa, Yedda M.L.S. de Matos, Henrique Douglas Melo Coutinho, Débora Feitosa Muniz, Irwin Rose Alencar de Menezes, Roger Henrique Sousa da Costa, Pedro Silvino Pereira, Saulo R. Tintino, Raimundo Luiz Silva Pereira, João Tavares Calixto Júnior, and José Maria Barbosa Filho
- Subjects
Staphylococcus aureus ,Microbial Sensitivity Tests ,medicine.disease_cause ,01 natural sciences ,Analytical Chemistry ,chemistry.chemical_compound ,Minimum inhibitory concentration ,0404 agricultural biotechnology ,Bacterial Proteins ,Ethidium ,Eugenol ,medicine ,Norfloxacin ,Binding Sites ,010401 analytical chemistry ,Hydrogen Bonding ,04 agricultural and veterinary sciences ,General Medicine ,040401 food science ,Anti-Bacterial Agents ,0104 chemical sciences ,Molecular Docking Simulation ,Isoeugenol ,Biochemistry ,chemistry ,Efflux ,Multidrug Resistance-Associated Proteins ,Antibacterial activity ,Ethidium bromide ,Food Science ,medicine.drug - Abstract
Staphylococcus aureus is a Gram-positive bacterium responsible for a number of diseases and has demonstrated resistance to conventional antibiotics. This study aimed to evaluate the antibacterial activity of eugenol and its derivatives allylbenzene, 4-allylanisole, isoeugenol and 4-allyl-2,6-dimethoxyphenol against the S. aureus NorA efflux pump (EP) in association with norfloxacin and ethidium bromide. The antibacterial activity of the compounds was assessed using the broth microdilution method to determine the minimum inhibitory concentration (MIC). A reduction in the MIC of ethidium bromide (a substrate for several efflux pumps) or norfloxacin was used as a parameter of EP inhibition. Molecular modeling studies were used to predict the 3D structure and analyze the interaction of selected compounds with the binding pocket of the NorA efflux pump. Except for 4-allylanisole and allylbenzene, the compounds presented clinically effective antibacterial activity. When associated with norfloxacin against the SA 1199B strain, 4-allyl-2,6-dimethoxyphenol eugenol and isoeugenol caused significant reduction in the MIC of the antibiotic, demonstrating synergistic effects. Similar effects were observed when 4-allyl-2,6-dimethoxyphenol, allylbenzene and isoeugenol were associated with ethidium bromide. Together, these findings indicate a potential inhibition of the NorA pump by eugenol and its derivatives. This in vitro evidence was corroborated by docking results demonstrating favorable interactions between 4-allyl-2,6-dimetoxypheno and the NorA pump mediated by hydrogen bonds and hydrophobic interactions. In conclusion, eugenol derivatives have the potential to be used in antibacterial drug development in strains carrying the NorA efflux pump.
- Published
- 2021
- Full Text
- View/download PDF